<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00169702</url>
  </required_header>
  <id_info>
    <org_study_id>F1D-SB-018</org_study_id>
    <nct_id>NCT00169702</nct_id>
  </id_info>
  <brief_title>The Effect of a Weight Management Program During Treatment With Olanzapine</brief_title>
  <official_title>The Effect of a Weight Management Program to Prevent Weight Gain and Metabolic Abnormalities During Treatment With the Atypical Neuroleptic Olanzapine: A Randomised Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Heinrich-Heine University, Duesseldorf</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Eli Lilly and Company</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Else Kröner-Fresenius-Centre for Nutritional Medicine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Technische Universität München</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Heinrich-Heine University, Duesseldorf</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study is a prospective, randomized, open-label study.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The principal objective of this trial is to investigate the effect of a comprehensive
      behavioural treatment program on weight gain in schizophrenic patients under olanzapine
      treatment, and on subjective well-being.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2003</start_date>
  <completion_date type="Actual">July 2007</completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>difference in mean weight gain</measure>
    <time_frame>November 2007</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>changes in waist circumference, blood pressure, blood lipids, fasting glucose</measure>
    <time_frame>November 2007</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">100</enrollment>
  <condition>Schizophrenia</condition>
  <arm_group>
    <arm_group_label>Standard</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>standard information</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intervention</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>weight management program, 12 sessions, 2 weekly, psychoeducational program, interactive topics like healthy food, diet behavior, physical activity, stress reduction.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>weight management program</intervention_name>
    <description>12 sessions, psychoeducation</description>
    <arm_group_label>Standard</arm_group_label>
    <arm_group_label>Intervention</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>weight management program</intervention_name>
    <description>2 weekly, 12 sessions, psychoeducational weight management</description>
    <arm_group_label>Standard</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV)
             criteria for schizophrenia

          -  Ages between 18 and 65

          -  Informed consent

          -  Weight gain of at least 1.5 kg in the first 4 weeks

          -  A sufficient understanding to participate adequately in the weight management program

          -  Patients must agree to cooperate with all tests and examinations required by the
             protocol.

          -  Each patient must understand the nature of the study and must sign an informed consent
             document.

        Exclusion Criteria:

          -  Serious, unstable somatic illnesses

          -  Illnesses associated with weight gain including renal and endocrine diseases

          -  Weight change greater than 3 kg in the preceding three months

          -  Weight gain less than 1.5 kg in the first 4 weeks
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joachim Cordes, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Psychiatry and Psychotherapy at the Heinrich-Heine-University Düsseldorf, Rhineland State Clinics Düsseldorf, Bergische Landstrasse 2, 40629 Düsseldorf, Germany</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ansgar Klimke, Prof</last_name>
    <role>Study Director</role>
    <affiliation>Department of Psychiatry, Offenbach</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Hans Hauner, Prof</last_name>
    <role>Study Director</role>
    <affiliation>Technical University of Munic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Heinrich-Heine-University, Rhineland State Clinics Düsseldorf</name>
      <address>
        <city>Düsseldorf</city>
        <state>Rhineland State</state>
        <zip>40629</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <reference>
    <citation>Hauner H, Rohrig K, Hebebrand J, Skurk T. (2003) No evidence for a direct effect of clozapine on fat-cell formation and production of leptin and other fat-cell-derived factors. Mol Psychiatry. 8 (3):258-9. Hauner H. (2001) Current pharmacological approaches to the treatment of obesity. Int J Obes Relat Metab Disord. 25 Suppl 1: 102-6. Cordes J, Agelink MW, Hauner H , Zielasek J. Metabolic syndrome in psychiatric disorders. The World Journal of Biological Psychiatry 2005, 6 Supplement 1: 342</citation>
  </reference>
  <verification_date>April 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 9, 2005</study_first_submitted>
  <study_first_submitted_qc>September 9, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 15, 2005</study_first_posted>
  <last_update_submitted>January 28, 2008</last_update_submitted>
  <last_update_submitted_qc>January 28, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 30, 2008</last_update_posted>
  <responsible_party>
    <name_title>Cordes, Joachim</name_title>
    <organization>Heinrich-Heine University</organization>
  </responsible_party>
  <keyword>Schizophrenia, weight management programme</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Schizophrenia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Olanzapine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

